These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 12364864)

  • 41. Adult liver transplantation and steroid-azathioprine withdrawal in cyclosporine (Sandimmun)-based immunosuppression - 5 year results of a prospective study.
    Lerut JP; Ciccarelli O; Mauel E; Gheerardhyn R; Talpe S; Sempoux C; Laterre PF; Roggen FM; Van Leeuw V; Otte JB; Gianello P
    Transpl Int; 2001 Dec; 14(6):420-8. PubMed ID: 11793040
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Minimization or withdrawal of immunosuppressants in pediatric liver transplant recipients.
    Lin NC; Wang HK; Yeh YC; Liu CP; Loong CC; Tsai HL; Chen CY; Chin T; Liu C
    J Pediatr Surg; 2015 Dec; 50(12):2128-33. PubMed ID: 26377868
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Late graft hepatitis and fibrosis in pediatric liver allograft recipients: Current concepts and future developments.
    Kelly D; Verkade HJ; Rajanayagam J; McKiernan P; Mazariegos G; Hübscher S
    Liver Transpl; 2016 Nov; 22(11):1593-1602. PubMed ID: 27543906
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prediction of liver allograft fibrosis after transplantation for hepatitis C virus: persistent elevation of serum transaminase levels versus necroinflammatory activity.
    Pelletier SJ; Iezzoni JC; Crabtree TD; Hahn YS; Sawyer RG; Pruett TL
    Liver Transpl; 2000 Jan; 6(1):44-53. PubMed ID: 10648577
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Centrilobular necrosis after orthotopic liver transplantation: association with acute cellular rejection and impact on outcome.
    Hassoun Z; Shah V; Lohse CM; Pankratz VS; Petrovic LM
    Liver Transpl; 2004 Apr; 10(4):480-7. PubMed ID: 15048789
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pediatric liver transplantation. A single center experience spanning 20 years.
    Jain A; Mazariegos G; Kashyap R; Kosmach-Park B; Starzl TE; Fung J; Reyes J
    Transplantation; 2002 Mar; 73(6):941-7. PubMed ID: 11923697
    [TBL] [Abstract][Full Text] [Related]  

  • 47. US-guided percutaneous liver biopsy in pediatric liver transplant recipients.
    Mandal S; Miraglia R; Maruzzelli L; Liotta R; Tuzzolino F; Spada M; Riva S; Luca A
    J Pediatr Gastroenterol Nutr; 2014 Jun; 58(6):756-61. PubMed ID: 24509302
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunological factors and liver fibrosis in pediatric liver transplant recipients.
    Markiewicz-Kijewska M; Kaliciński P; Kluge P; Piątosa B; Jankowska I; Rękawek A; Kostecka E; Kurowski PN
    Ann Transplant; 2015 May; 20():279-84. PubMed ID: 25981858
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Delayed onset of severe hepatitis C-related liver damage following liver transplantation: a matter of concern?
    Berenguer M; Aguilera V; Prieto M; Carrasco D; Rayón M; San Juan F; Landaverde C; Mir J; Berenguer J
    Liver Transpl; 2003 Nov; 9(11):1152-8. PubMed ID: 14586875
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serum Mac-2 binding protein glycosylation isomer predicts the activation of hepatic stellate cells after liver transplantation.
    Yamada N; Katano T; Hirata Y; Okada N; Sanada Y; Ihara Y; Urahashi T; Ushijima K; Karasawa T; Takahashi M; Mizuta K
    J Gastroenterol Hepatol; 2019 Feb; 34(2):418-424. PubMed ID: 30101431
    [TBL] [Abstract][Full Text] [Related]  

  • 51. All liver recipients benefit from the protocol 10-year liver biopsies.
    Sebagh M; Rifai K; Féray C; Yilmaz F; Falissard B; Roche B; Bismuth H; Samuel D; Reynès M
    Hepatology; 2003 Jun; 37(6):1293-301. PubMed ID: 12774007
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Magnetic resonance elastography and biomarkers to assess fibrosis from recurrent hepatitis C in liver transplant recipients.
    Lee VS; Miller FH; Omary RA; Wang Y; Ganger DR; Wang E; Rao S; Levitsky J
    Transplantation; 2011 Sep; 92(5):581-6. PubMed ID: 21822174
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Central venulitis in pediatric liver allografts.
    Krasinskas AM; Ruchelli ED; Rand EB; Chittams JL; Furth EE
    Hepatology; 2001 May; 33(5):1141-7. PubMed ID: 11343242
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical and histologic patterns of early graft failure due to recurrnet hepatitis C in four patients after liver transplantation.
    Dickson RC; Caldwell SH; Ishitani MB; Lau JY; Driscoll CJ; Stevenson WC; McCullough CS; Pruett TL
    Transplantation; 1996 Mar; 61(5):701-5. PubMed ID: 8607170
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anti-lymphocyte therapy successfully controls late "cholestatic" rejection in pediatric liver transplant recipients.
    Kerkar N; Morotti RA; Iyer K; Arnon R; Miloh T; Sturdevant M; Suchy F; Florman S; Emre S
    Clin Transplant; 2011; 25(6):E584-91. PubMed ID: 21919961
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Timing and severity of initial hepatitis C recurrence as predictors of long-term liver allograft injury.
    Rosen HR; Gretch DR; Oehlke M; Flora KD; Benner KG; Rabkin JM; Corless CL
    Transplantation; 1998 May; 65(9):1178-82. PubMed ID: 9603164
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The prevalence and natural history of untreated isolated central perivenulitis in adult allograft livers.
    Krasinskas AM; Demetris AJ; Poterucha JJ; Abraham SC
    Liver Transpl; 2008 May; 14(5):625-32. PubMed ID: 18433038
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Low-dose steroids associated with milder histological changes after pediatric liver transplantation.
    Kosola S; Lampela H; Jalanko H; Mäkisalo H; Lohi J; Arola J; Pakarinen MP
    Liver Transpl; 2013 Feb; 19(2):145-54. PubMed ID: 23109058
    [TBL] [Abstract][Full Text] [Related]  

  • 59. What have we learned about primary liver transplantation under tacrolimus immunosuppression? Long-term follow-up of the first 1000 patients.
    Jain A; Reyes J; Kashyap R; Rohal S; Abu-Elmagd K; Starzl T; Fung J
    Ann Surg; 1999 Sep; 230(3):441-8; discussion 448-9. PubMed ID: 10493490
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Are parenchymal changes in early post-transplant biopsies related to preservation-reperfusion injury or rejection?
    Neil DA; Hubscher SG
    Transplantation; 2001 Jun; 71(11):1566-72. PubMed ID: 11435966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.